Advertisement
#vaksin-takeda
Ahad , 28 Aug 2022, 16:05 WIB
BPOM RI Setujui Penggunaan Vaksin DBD untuk Usia 6-45 Tahun
REPUBLIKA.CO.ID, JAKARTA — Badan Pengawas Obat dan Makanan (BPOM) telah menyetujui Vaksin Dengue Tetravalen dari Takeda untuk digunakan pada individu berusia enam hingga 45 Tahun. Perlu diketahui bahwa saat ini,...
Sabtu , 05 Jun 2021, 08:13 WIB
Dengue Vaccine Candidate Reinforced by Long-Term Safety
REPUBLIKA.CO.ID, JAKARTA -- Takeda Pharmaceutical Company Limited (Takeda) announced that its dengue vaccine candidate (TAK-003) demonstrated continued protection against dengue illness and hospitalization, regardless of an individual's previous dengue exposure, with no important safety risks identified through three years after vaccination in the ongoing pivotal Phase 3 Tetravalent Immunization against Dengue Efficacy Study (TIDES) trial. TIDES enrolled more than...
Jumat , 28 May 2021, 18:46 WIB
Calon Vaksin DBD Takeda Mampu Cegah DBD hingga 62 Persen
REPUBLIKA.CO.ID, JAKARTA -- Takeda Pharmaceutical Company Limited (Takeda) mengumumkan...